Impact of preoperative screening for rectal colonization with fluoroquinolone-resistant enteric bacteria on the incidence of sepsis following transrectal ultrasound guided prostate biopsy

Research and Reports in Urology

Volumn 9, Issue , 2017, Pages 37-41

  Farrell, John J ^a,b   Hicks, Jennifer L ^b   Wallace, Stephanie E ^b   Seftel, Allen D ^c,d  

^a UNIVERSITY OF ILLINOIS   (United States)

^b OSF SAINT FRANCIS MEDICAL CENTER   (United States)

^c Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^d Cooper University School of Medicine ^*  (United States)

Author keywords

Antimicrobial stewardship; Gram negative infections; Preoperative antibiotic prophylactic treatment; Sepsis

Indexed keywords

CEFALEXIN; CEFUROXIME; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; ENTEROBACTERIACEAE; HUMAN; HUMAN TISSUE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MIDDLE AGED; NONHUMAN; PROSPECTIVE STUDY; PROSTATE BIOPSY; SEPSIS; TRANSRECTAL ULTRASONOGRAPHY;

EID: 85020845714     PISSN: None     EISSN: 22532447     Source Type: Journal    
DOI: 10.2147/RRU.S117206     Document Type: Article

References (8)

1. Zani EL, Clark OA, Rodrigues Netto N. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. 2011; 11(5):CD006576.
2. Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4): 1151–1161.
3. Centers for Disease Control and Prevention [webpage on the Internet]. Antibiotic resistance threats in the United States, 2013. Available from: http://www.cdc.gov/drugresistance/threat-report-2013/. Accessed December 7, 2017.
4. Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943–950.
5. Luong B, Danforth T, Visnjevac O, Suraf M, Duff M, Chevli KK. Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies. Urology. 2015;85(3):511–516.
6. Yang L, Gao L, Chen Y, et al. Prophylactic antibiotics in prostate biopsy: a meta-analysis based on randomized controlled trials. Surg Infect. 2015; 16(6):733–747.
7. Waltz P, Zuckerbraun B. Novel therapies for severe Clostridium difficile colitis. Curr Opin Crit Care. 2016;22(2):167–173.
8. Dalhoff A. Global fluoroquinolone resistance epidemiology and implications for clinical use. Interdiscip Perspect Infect Dis. 2012; 2012: 976273